Impact of diabetes among revascularized patients in Japan and the U.S.

Diabetes Care

Volumn 35, Issue 3, 2012, Pages 654-659

  Kohsaka, Shun ^a   Komeda, Masashi ^f   Goto, Masashi ^b   Sakata, Ryuzo ^g   Nagai, Toshiyuki ^a   Ohsugi, Mitsuru ^h   Lee, Vei Vei ^c   Fukuda, Keiichi ^a   Elayda, Macarthur ^c   Wilson, James M ^c   Furukawa, Yutaka ^d   Kita, Toru ^d   Fukushima, Masanori ^e   Kimura, Takeshi ^g  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

^f Nagoya Heart Center   (Japan)

^g KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE REGISTRY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; JAPAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; SURGICAL MORTALITY; SURVIVAL RATE; UNITED STATES;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; DIABETES MELLITUS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; UNITED STATES;

EID: 84859075295     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1547     Document Type: Article

References (19)

1. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of amultifactorial intervention onmortality in type 2 diabetes. N Engl J Med 2008;358:580-591 (Pubitemid 351214285)
2. Daemen J, Kuck KH, Macaya C, et al.; ARTS-II Investigators.Multivessel coronary revascularization in patients with and without diabetesmellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol 2008;52:1957-1967
3. Frye RL, August P, Brooks MM, et al.; BARI 2DStudy Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360:2503-2515
4. Banning AP,Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 2010;55:1067-1075
5. Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N. Review article: diabetes, genetics and ethnicity. Aliment Pharmacol Ther 2005;22(Suppl. 2):16-19 (Pubitemid 41564375)
6. National Center for Health Statistics. Health, United States, 2005: With Chartbook on Trends in the Health of Americans. Washington, DC, U.S. Govt. Printing Office, 2005
7. Kimura T, Morimoto T, Nakagawa Y, et al.; j-Cypher Registry Investigators. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009;119:987-995
8. Kohsaka S, Kimura T, Goto M, et al. Difference inpatient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol 2010;105:1698-1704
9. Kuzuya T, Nakagawa S, Satoh J, et al.; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002;55: 65-85 (Pubitemid 34036538)
10. Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity ofregression results to unmeasured confounders in observational studies. Biometrics 1998;54:948-963 (Pubitemid 28429289)
11. Motomura N, Miyata H, Tsukihara H, OkadaM, Takamoto S; Japan Cardiovascular Surgery Database Organization. First report on30-day and operative mortality in risk model of isolated coronary artery bypass grafting in Japan. Ann Thorac Surg 2008; 86:1866-1872
12. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in theWorld Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612
13. Steg PG, Bhatt DL, Wilson PW, et al.; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297: 1197-1206 (Pubitemid 46465728)
14. Tada T, Kimura T, Morimoto T, et al.; j-Cypher Registry Investigators. Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry. Am J Cardiol 2011;107: 1155-1162
15. Ohmura T, Ueda K, Kiyohara Y, et al. The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDMin the Japanese general population: the Hisayama study. Diabetologia 1994;37: 897-904 (Pubitemid 24288029)
16. Fukushima M, Usami M, Ikeda M, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 2004;53:831-835 (Pubitemid 38829453)
17. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997;336:1046-1053 (Pubitemid 27163856)
18. Yokoyama M, Origasa H, Matsuzaki M, et al.; Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid onmajor coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-1098 (Pubitemid 46483662)
19. Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA 2008;299:2868-2876 (Pubitemid 351930886)